يعرض 1 - 20 نتائج من 185 نتيجة بحث عن '"MESH: Spike Glycoprotein"', وقت الاستعلام: 0.84s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: Pathologies Pulmonaires et Plasticité Cellulaire - UMR-S 1250 (P3CELL), Université de Reims Champagne-Ardenne (URCA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service des maladies respiratoires et allergiques CHU Reims, Hôpital universitaire Robert Debré Reims (CHU Reims), Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Neurobiologie intégrative des Systèmes cholinergiques / Integrative Neurobiology of Cholinergic Systems (NISC), Institut Pasteur Paris (IP)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Hôpital Maison Blanche, This work was supported by funding from the University of Reims Champagne-Ardenne (URCA), the French National Institute of Health and Medical Research (Inserm), and the National Agency for Research (ANR, RA-COVID-19)., ANR-20-COVI-0021,AM-Cov-Path,Pathogénèse de l'infection SARS-Cov-2 dans un modèle de primates non humains : un modèle pour les traitements et la prévention(2020)

    المصدر: ISSN: 0306-9877 ; Medical Hypotheses ; https://pasteur.hal.science/pasteur-03509149 ; Medical Hypotheses, 2022, 158, pp.110741. ⟨10.1016/j.mehy.2021.110741⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34924680; pasteur-03509149; https://pasteur.hal.science/pasteur-03509149; https://pasteur.hal.science/pasteur-03509149/document; https://pasteur.hal.science/pasteur-03509149/file/S0306987721002607.pdf; PII: S0306-9877(21)00260-7; PUBMED: 34924680; PUBMEDCENTRAL: PMC8669939

  2. 2
    Academic Journal

    المساهمون: Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), Immunologie des maladies virales, auto-immunes, hématologiques et bactériennes (IMVA-HB), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Department of Medical Microbiology and Infection Prevention Amsterdam, University of Amsterdam Amsterdam = Universiteit van Amsterdam (UvA), Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae Paris (CNR - laboratoire coordonnateur), Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), This work acknowledges support by the European Union's Horizon 2020 research and innovation program under grant agreement no. 681032, H2020 EHVA (W.W.), the ANR, RA-Covid-19 (W.W. and R.l.G.), and the CNRS (W.W.). W.W. acknowledges access to the platforms of the Grenoble Instruct-ERIC center (IBS and ISBG, UMS 3518 CNRS-CEA-UGA-EMBL) within the Grenoble Partnership for Structural Biology (PSB), with support from FRISBI (ANR-10-INBS-05-02) and GRAL, a project of the University Grenoble Alpes graduate school (Ecoles Universitaires de Recherche) CBH-EUR-GS (ANR-17-EURE-0003). The IBS acknowledges integration into the Interdisciplinary Research Institute of Grenoble (IRIG, CEA) and financial support from CEA, CNRS, and UGA. The Infectious Disease Models and Innovative Therapies (IDMIT) research infrastructure is supported by the Program Investissements d’Avenir, managed by the National Research Agency (ANR) under reference ANR-11-INBS-0008. The Fondation Bettencourt Schueller and the Region Ile-de-France contributed to the implementation of IDMIT’s facilities and imaging technologies. The NHP study received financial support from REACTing, the Fondation pour la Recherche Médicale (AM-CoV-Path), and the European Infrastructure TRANSVAC2 (730964). We acknowledge support from CoVIC, supported by the Bill and Melinda Gates Foundation. The virus stock was obtained through the EVAg platform (https://www.european-virus-archive.com/), funded by H2020 (653316)., ANR-10-INBS-0005,FRISBI,Infrastructure Française pour la Biologie Structurale Intégrée(2010), ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017), ANR-11-INBS-0008,IDMIT,Infrastructure nationale pour la modélisation des maladies infectieuses humaines(2011), European Project: 681032,H2020,H2020-PHC-2015-single-stage_RTD,EHVA(2016), European Project: 730964, H2020, RIA,H2020-INFRAIA-2016-1,TRANSVAC2(2017), European Project: 653316,H2020,H2020-INFRAIA-2014-2015,EVAg(2015)

    المصدر: ISSN: 2666-3791 ; Cell Reports Medicine ; https://hal.univ-grenoble-alpes.fr/hal-03621344 ; Cell Reports Medicine, 2022, 3 (2), pp.100528. ⟨10.1016/j.xcrm.2022.100528⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35233549; info:eu-repo/grantAgreement//681032/EU/European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates/EHVA; info:eu-repo/grantAgreement//730964/EU/European Vaccine Research and Development Infrastructure/TRANSVAC2; info:eu-repo/grantAgreement//653316/EU/European Virus Archive goes global/EVAg; PUBMED: 35233549; PUBMEDCENTRAL: PMC8784613

  3. 3
    Academic Journal

    المساهمون: Découverte de pathogènes – Pathogen discovery, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Centre Collaborateur de l'OIE de Détection et identification chez l’homme des pathogènes animaux émergents et développement d’outils pour leur diagnostic / Collaborating Center for the Detection and identification in humans of emerging animal pathogens and development of tools for their diagnoses (CCOIE-OIECC), Institut Pasteur Paris (IP)-Organisation Mondiale de la Santé Animale / World Organisation Animal Health Paris (OIE)-Université Paris Cité (UPCité), Institut Pasteur du Laos, Pasteur Network (Réseau International des Instituts Pasteur), Virologie Structurale - Structural Virology, Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Bioinformatique structurale - Structural Bioinformatics, National University of Laos, Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae Paris (CNR - laboratoire coordonnateur), Hub Bioinformatique et Biostatistique - Bioinformatics and Biostatistics HUB, École nationale vétérinaire d'Alfort (ENVA), NGS was performed with the help of the Biomics Platform, Center for Technological Resources and Research, Institut Pasteur, Paris, France, supported by France Génomique (ANR-10-INBS-09-09), Inclusive Blockchain Insurance using Space Assets and the Illumina COVID-19 Projects’ offer. The work was granted access to the High Performance Computing resources of the Institute for Development and Resources in Intensive Scientific Computing under the allocation 2020-101592 made by Grand Équipement National de Calcul Intensif. We thank the Ministry of Health and the Ministry of Natural Resources and Environments, Lao People’s Democratic Republic, for their authorization of the field work and the Faculty of Environmental Science for its authorization of the field research collaboration. The work was supported by an Institut Pasteur 'Covid Taskforce' and in part by the H2020 project 101003589 (RECOVER) and Labex IBEID (ANR-10-LABX62-IBEID) grants. Field and laboratory work at IPL was also supported by a UK embassy grant (grant no. INT 2021/LOV C19 02) and a Luxembourg Development special grant (grant no. LAO/030·202324)., We thank S. Mohamed Ali, N. Da Rocha, A. Brisebarre, T. Xaybounsou and S. Chonephetsarath for their help at the bench, A. Haouz and the staff of the protein crystallogenesis facility at Institut Pasteur for help with crystallization trials, P. England from the Molecular Biophysics facility at Institut Pasteur for his support and access to the BLI equipment, P. Legrand from the PX1 beamline at Synchrotron SOLEIL for data collection support, and P. Guardado-Calvo for discussion and support with BLI experiments., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-10-INBS-0009,France Génomique,Organisation et montée en puissance d'une Infrastructure Nationale de Génomique(2010), European Project: 101003589, H2020-SC1-PHE-CORONAVIRUS-2020,RECOVER(2020)

    المصدر: ISSN: 0028-0836.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35172323; info:eu-repo/grantAgreement//101003589/EU/Rapid European COVID-19 Emergency Response research/RECOVER; PUBMED: 35172323

  4. 4
    Academic Journal

    المساهمون: Institut Pasteur du Cambodge, Pasteur Network (Réseau International des Instituts Pasteur), Communicable Disease Department Phnom Penh (CDC MOH), Ministry of Health Mozambique, Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Vaccine Research Institute Créteil, France (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), The Howard Hughes Medical Institute (HHMI)–Wellcome Trust (208710/Z/17/Z to TC), « URGENCE COVID-19 » fundraising campaign of Institut Pasteur (TC, HA, and PD). HA is supported by the German Centre for International Migration and Development (CIM).

    المصدر: ISSN: 1664-3224.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35185909; PUBMED: 35185909; PUBMEDCENTRAL: PMC8853741

  5. 5
    Academic Journal

    المساهمون: Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Vaccine Research Institute Créteil, France (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Immunologie humorale - Humoral Immunology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Génomique évolutive des virus à ARN - Evolutionary genomics of RNA viruses, Institut Pasteur Paris (IP), Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Génomique fonctionnelle des tumeurs solides = Functional Genomics of Solid Tumors CRC (FunGeST), Centre de Recherche des Cordeliers (CRC (UMR_S_1138 / U1138)), École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité)-École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Université Paris Cité (UPCité), Centre Hospitalier Régional d'Orléans (CHRO), Virologie Structurale - Structural Virology, Work in OS lab is funded by Institut Pasteur, Fondation pour la Recherche Médicale (FRM), Urgence COVID-19 Fundraising Campaign of Institut Pasteur, ANRS, the Vaccine Research Institute (ANR-10-LABX-77), Labex IBEID (ANR-10-LABX-62-IBEID), ANR/FRM Flash Covid PROTEO-SARS-CoV-2 and IDISCOVR. Work in UPBI is funded by grant ANR-10-INSB-04-01 and Région Ile-de-France program DIM1-Health. NS is supported by the French Ministry of Higher Education, Research and Innovation. DP is supported by the Vaccine Research Institute. HM lab is funded by the Institut Pasteur, the Milieu Intérieur Program (ANR-10-LABX-69-01), the INSERM, REACTing, EU (RECOVER) and Fondation de France (#00106077) grants. ESL lab is funded by Institut Pasteur and the French Government's Investissement d'Avenir programme, Laboratoire d'Excellence “Integrative Biology of Emerging Infectious Diseases” (grant n°ANR-10-LABX-62-IBEID)., ANR-10-LABX-0077,VRI,Initiative for the creation of a Vaccine Research Institute(2010), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-10-LABX-0069,MILIEU INTERIEUR,GENETIC & ENVIRONMENTAL CONTROL OF IMMUNE PHENOTYPE VARIANCE: ESTABLISHING A PATH TOWARDS PERSONALIZED MEDICINE(2010)

    المصدر: ISSN: 2352-3964 ; EBioMedicine ; https://pasteur.hal.science/pasteur-03654246 ; EBioMedicine, 2022, 77, pp.103934. ⟨10.1016/j.ebiom.2022.103934⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35290827; PUBMED: 35290827; PUBMEDCENTRAL: PMC8917961

  6. 6
    Academic Journal

    المساهمون: Epidémiologie et Analyse des Maladies Infectieuses - Infectious Disease Epidemiology and Analytics, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Tallaght Hospital, Trinity College Dublin, Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre Hospitalier Régional d'Orléans (CHRO), Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Institut National de la Santé et de la Recherche Médicale (INSERM), Immuno-Rhumatologie Moléculaire (IRM), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), This work was supported by the Fondation pour la Recherche Médicale (CorPopImm to MW), the French Government’s Laboratoire d’Excellence “Integrative Biology of Emerging Infectious Diseases” (Investissement d’Avenir grant n°ANR-10-LABX-62-IBEID), and INCEPTION programs (Investissement d’Avenir grant ANR-16-CONV-0005). SFK’s laboratory is funded by Strasbourg University Hospitals (SeroCoV-HUS, PRI 7782), the Agence Nationale de la Recherche (ANR-18-CE17–0028), Laboratoire d’Excellence TRANSPLANTEX (ANR-11-LABX-0070_TRANSPLANTEX) and Institut National de la Santé et de la Recherche Médicale (UMR_S 1109). The NH-COVAIR Study was funded by a grant from the Meath Foundation, Tallaght University Hospital. A.H.D. has been awarded the Irish Clinical Academic Training (ICAT) Programme, supported by the Wellcome Trust and the Health Research Board (Grant Number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning, and the Health and Social Care, Research and Development Division, Northern Ireland. N.B. is funded under the Science Foundation Ireland Phase 2 COVID-19 Rapid Response Call (20/COV/8487) and the Health Research Board COVID-19 Rapid Response Call (COV19e2020e053)., The authors are grateful to healthcare workers and nursing home residents who participated in this study., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-16-CONV-0005,INCEPTION,Institut Convergences pour l'étude de l'Emergence des Pathologies au Travers des Individus et des populatiONs(2016), ANR-11-LABX-0070,TRANSPLANTEX,Nouveaux loci d'histocompatibilité/biomarqueurs en transplantation humaine: de la découverte à l'app(2011)

    المصدر: ISSN: 1999-4915 ; Viruses ; https://pasteur.hal.science/pasteur-04082742 ; Viruses, 2022, Special Issue SARS-CoV-2 Research in France, 14 (7), pp.1491. ⟨10.3390/v14071491⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35891471; PUBMED: 35891471; PUBMEDCENTRAL: PMC9321390

  7. 7
    Academic Journal

    المساهمون: Université Pascal Paoli (UPP), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Unité des Virus Emergents (UVE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), European Project: 871029,H2020,H2020-INFRAIA-2019-1,EVA-GLOBAL(2020)

    المصدر: ISSN: 1661-7827.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36429974; info:eu-repo/grantAgreement//871029/EU/European Virus Archive GLOBAL/EVA-GLOBAL; PUBMED: 36429974; PUBMEDCENTRAL: PMC9691066

  8. 8
    Academic Journal

    المساهمون: Institut des Maladies Métaboliques et Casdiovasculaires (UPS/Inserm U1297 - I2MC), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire Hématologie - Rangueil CHU Toulouse, Pôle Biologie CHU Toulouse, Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)

    المصدر: ISSN: 1664-3224.

  9. 9
    Academic Journal

    المساهمون: German Primate Center - Deutsches Primatenzentrum - Leibniz Insitute for Primate Research Göttingen (GPC - DPZ), Leibniz Gemeinschaft, Georg-August-University = Georg-August-Universität Göttingen, Medizinische Hochschule Hannover = Hannover Medical School (MHH), Charité - UniversitätsMedizin = Berlin University Medicine, Helmholtz-Zentrum für Infektionsforschung GmbH (HZI), German Center for Infection Research - partner site Hannover-Braunschweig (DZIF), Génomique évolutive des virus à ARN - Evolutionary genomics of RNA viruses, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Centre National de Référence des virus respiratoires (dont la grippe et le SARS-CoV2) Paris (CNR - laboratoire associé), Friedrich-Alexander Universität Erlangen-Nürnberg = University of Erlangen-Nuremberg (FAU), Helmholtz Centre for Infection Research (HZI), L.Z. acknowledges funding by the China Scholarship Council (CSC) (202006270031). E.S.-L. acknowledges funding from Institut Pasteur, the HERA Project DURABLE (grant no. 101102733), the NIH PICREID (grant no. U01AI151758), and Sante publique France to the French National Reference Center for Viruses of Respiratory Infections. H.-M.J. received funding from BMBF (01KI2043, NaFoUniMedCovid19-COVIM: 01KX2021), Bavarian State Ministry for Science and the Arts and Deutsche Forschungsgemeinschaft (DFG) through the research training groups RTG1660 and TRR130, the Bayerische Forschungsstiftung (Project CORAd), and the Kastner Foundation. L.C.-S. was supported by the COVID-19-Research Network Lower Saxony (COFONI) through funding from the Ministry of Science and Culture of Lower Saxony in Germany (14-76103-184, project 6FF22). G.M.N.B. acknowledges funding by German Center for Infection Research (grant no. 80018019238), and G.M.N.B. and A.D.-J. acknowledge funding by a European Regional Development Fund (Defeat Corona, ZW7-8515131) and the Ministry for Science and Culture of Lower Saxony (Niedersächsisches Ministerium für Wissenschaft und Kultur, 14-76103-184, COFONI Network, project 4LZF23). C.D. acknowledges funding by the European Commission Health Emergency Preparedness and Response Authority (HERA, grant 101102733), German Center for Infection Research, National Network University Medicine project GenSurv (01KX2121), and the German Ministry of Health through grant SeroVarCov (2522 NIK 002). S.P. acknowledges funding by the EU project UNDINE (grant agreement no. 101057100), the COVID-19-Research Network Lower Saxony (COFONI) through funding from the Ministry of Science and Culture of Lower Saxony in Germany (14-76103-184, projects 7FF22, 6FF22, 10FF22), and the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, PO 716/11-1). Funding sources had no role in the design and execution of the study, the writing of the manuscript, and the decision to submit the manuscript for publication. The authors did not receive payment by a pharmaceutical company or other agency to write the publication. The authors were not precluded from accessing data in the study, and they accept responsibility to submit for publication.

    المصدر: ISSN: 0092-8674.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/38194966; PUBMED: 38194966; PUBMEDCENTRAL: PMC11317634

  10. 10
    Academic Journal

    المساهمون: Epidémiologie et Analyse des Maladies Infectieuses - Infectious Disease Epidemiology and Analytics, Institut Pasteur Paris (IP), Malaria : parasites et hôtes - Malaria : parasites and hosts, Virologie Moléculaire et Vaccinologie / Molecular Virology and Vaccinology, Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Centre Hospitalier de Mulhouse, site du Hasenrain (Mulhouse), Centre Hospitalier Simone Veil de Beauvais Beauvais, Centre hospitalier régional Metz-Thionville (CHR Metz-Thionville), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ), Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie, Laboratoire de Virologie CHU Amiens, CHU Amiens-Picardie, Hôpitaux Civils de Colmar, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Centre d’Investigation Clinique de Nantes (CIC Nantes), Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Service de Pédiatrie CHRU Nancy, Centre de Ressources Biologiques - Nancy (CRB Nancy), Hôpitaux Pédiatriques de Nice Lenval (CHU-Lenval), Centre Hospitalier Universitaire de Nice (CHU Nice), Centre Hospitalier Universitaire de Saint-Etienne CHU Saint-Etienne (CHU ST-E), agence régionale de santé Hauts-de-France (ARS), Investigation Clinique et d’Accès aux Ressources Biologiques (Plate-forme) - Clinical Investigation and Access to BioResources (ICAReB), Direction de la recherche médicale de l'Institut Pasteur, Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae Paris (CNR - laboratoire coordonnateur), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM)-Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), Conservatoire National des Arts et Métiers CNAM (CNAM), This work was supported by the « URGENCE COVID-19 » fundraising campaign of Institut Pasteur, by the French Government's Investissement d'Avenir program, Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases (Grant No. ANR-10-LABX-62-IBEID), and by the REACTing (Research & Action Emerging Infectious Diseases) and the RECOVER project funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No. 101003589., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), European Project: 101003589, H2020-SC1-PHE-CORONAVIRUS-2020,RECOVER(2020)

    المصدر: ISSN: 2352-3964 ; EBioMedicine ; https://u-picardie.hal.science/hal-03591559 ; EBioMedicine, 2021, 70, pp.103495. ⟨10.1016/j.ebiom.2021.103495⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34304047; info:eu-repo/grantAgreement//101003589/EU/Rapid European COVID-19 Emergency Response research/RECOVER; hal-03591559; https://u-picardie.hal.science/hal-03591559; https://u-picardie.hal.science/hal-03591559/document; https://u-picardie.hal.science/hal-03591559/file/1-s2.0-S2352396421002887-main.pdf; PUBMED: 34304047; PUBMEDCENTRAL: PMC8299153

  11. 11
    Academic Journal

    المساهمون: Génomique évolutive des virus à ARN - Evolutionary genomics of RNA viruses, Institut Pasteur Paris (IP)-Université Paris Cité (UPCité), Institut de Recherche Biomédicale des Armées Brétigny-sur-Orge (IRBA), Université Paris-Saclay, Unité de Virologie / Virology Unit Phnom Penh, Institut Pasteur du Cambodge, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur), Unité des Virus Emergents (UVE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Systématique, Evolution, Biodiversité (ISYEB), Muséum national d'Histoire naturelle (MNHN)-École Pratique des Hautes Études (EPHE), Université Paris Sciences et Lettres (PSL)-Université Paris Sciences et Lettres (PSL)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Université des Antilles (UA), Université Paris Cité (UPCité), Wildlife Conservation Society Phnom Penh, Cambodia, Wildlife Conservation Society (WCS), University of California Davis (UC Davis), University of California (UC), This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project (cooperative agreement number GHN-A-OO-09-00010-00 and AID-OAA-A-14-00102), with a specific extension for the testing reported here. V.H. is supported by a scholarship from the French Government (BGF) for his Ph.D. E.S.L. acknowledges funding from the French Government’s Investissement d’Avenir program, ‘INCEPTION’ (ANR-16-CONV-0005), and Laboratoire d’Excellence ‘Integrative Biology of Emerging Infectious Diseases’ (ANR-10-LABX-62-IBEID). In 2010, the fieldwork was supported by the National Authority for Preah Vihear, UNESCO, “Société des amis du Muséum et du Jardin des Plantes”, and the Muséum national d’Histoire naturelle., ANR-16-CONV-0005,INCEPTION,Institut Convergences pour l'étude de l'Emergence des Pathologies au Travers des Individus et des populatiONs(2016), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010)

    المصدر: ISSN: 2041-1723.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34753934; PUBMED: 34753934; PUBMEDCENTRAL: PMC8578604

  12. 12
    Academic Journal

    المساهمون: Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Université Paris Cité (UPCité), Immuno-Rhumatologie Moléculaire (IRM), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Les Hôpitaux Universitaires de Strasbourg (HUS), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM)-Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), CIC Strasbourg (Centre d’Investigation Clinique Plurithématique (CIC - P)), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Nouvel Hôpital Civil de Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Hôpital de Hautepierre Strasbourg, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Groupe Méthodes en Recherche Clinique Strasbourg (GMRC), Nouvel Hôpital Civil de Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS)-Les Hôpitaux Universitaires de Strasbourg (HUS), Immunologie humorale - Humoral Immunology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Vaccine Research Institute Créteil, France (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), S. F. K.’s laboratory is funded by Strasbourg University Hospitals (Hôpitaux Universitaires de Strasbourg, PRI 7782), Agence Nationale de la Recherche (ANR-18-CE17-0028), Laboratoire d’Excellence TRANSPLANTEX (ANR-11-LABX-0070_TRANSPLANTEX), and Institut National de la Santé et de la Recherche Médicale (UMR_S 1109). O. S.’s laboratory is funded by Institut Pasteur, Urgence COVID-19 Fundraising Campaign of Institut Pasteur, Agence Nationale de recherches sur le sida, Sidaction, the Vaccine Research Institute (ANR-10-LABX-77), Labex IBEID (ANR-10-LABX-62-IBEID), “TIMTAMDEN” Agence Nationale de la Recherche ANR-14-CE14-0029, “CHIKV-Viro-Immuno” ANR-14-CE14-0015-01, the Gilead HIV cure program, and ANR/Fondation Pour la Recherche Médicale Flash COVID. L. Gr., is supported by the French Ministry of Higher Education, Research and Innovation., ANR-18-CE17-0028,HuMABK,Les anticorps monoclonaux humains : une Nouvelle approche thérapeutique contre l'infection par le virus BK et les maladies associées(2018), ANR-11-LABX-0070,TRANSPLANTEX,Nouveaux loci d'histocompatibilité/biomarqueurs en transplantation humaine: de la découverte à l'app(2011), ANR-10-LABX-0077,VRI,Initiative for the creation of a Vaccine Research Institute(2010), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-14-CE14-0029,TIMTAMDEN,Rôle des récepteurs TIM et TAM dans l'infection des cellules cibles par le virus de la dengue(2014), ANR-14-CE14-0015,CHIKV-Viro-Immuno,Multiplication et Relation avec l'hôte du virus Chikungunya(2014)

    المصدر: ISSN: 0022-1899.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/33693749; PUBMED: 33693749; PUBMEDCENTRAL: PMC7989436

  13. 13
    Academic Journal

    المساهمون: CHU Henri Mondor Créteil, Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Paris-Est Créteil Val-de-Marne - Faculté de médecine (UPEC Médecine), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)

    المصدر: ISSN: 1046-6673.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/33637518; PUBMED: 33637518

  14. 14
    Academic Journal

    المساهمون: Xenothera Nantes, France, Institut Pierre Louis d'Epidémiologie et de Santé Publique (iPLESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), CHU Pitié-Salpêtrière AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), The University of Hong Kong (HKU), Centre Hospitalier Universitaire de Nantes = Nantes University Hospital (CHU Nantes), Institut Pasteur Paris (IP), The Chinese University of Hong Kong Hong Kong (CUHK), This work was supported by Xenothera, the Agence Nationale de la Recherche sur le SIDA et les Maladies Infectieuses Emergentes (ANRS MIE), AC43 Medical Virology and Emergen Program, the SARS-CoV-2 Program of the Faculty of Medicine of Sorbonne Université and by Bpifrance, grant «Projet de Recherche et Développement Structurant Pour la Compétitivité spécifique à la crise sanitaire COVD-19—POLYCOR» and the National Research Foundation of Korea (NRF) grant funded through the Korea government (NRF-2018M3A9H4055203)., We sincerely thank Prof. Xavier de Lamballerie and Dr. Franck Touret from UMR IRD 190, Inserm 1207 “Unité des Virus Émergents,” Aix-Marseille Université for their active technical contribution to generating neutralization data and for their advice. We also thank the virology departments of Saint-Antoine and Avicenne Universitary hospitals who gently shared the clinical specimen allowing us to isolate the Gamma/P.1 and Delta/B.1.617.2 variants, respectively. We also thank Prof. Jincun Zhao and Yanqun Wang for providing us the adenovirus that carries the human ACE-2

    المصدر: ISSN: 1664-3224.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34868003; hal-03469286; https://hal.sorbonne-universite.fr/hal-03469286; https://hal.sorbonne-universite.fr/hal-03469286/document; https://hal.sorbonne-universite.fr/hal-03469286/file/fimmu-12-761250.pdf; PUBMED: 34868003; PUBMEDCENTRAL: PMC8634597

  15. 15
    Academic Journal

    المساهمون: Virus, Vecteurs et Hôtes Tunis, Institut Pasteur de Tunis, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur), Université de Tunis El Manar (UTM), Laboratoire de Bioinformatique, biomathématiques, biostatistiques (BIMS) (LR11IPT09), Université de Tunis El Manar (UTM)-Institut Pasteur de Tunis, Université de Monastir - University of Monastir (UM), Ministère de la santé Publique Tunisie, This work was cofunded by the Tunisian Ministry of Higher Education and Research and the European Union’s Horizon 2020 research and innovation program under grant agreement no. 883441, project STAMINA (demonstration of intelligent decision support for pandemic crisis prediction and management within and across European borders)., European Project: 883441,H2020-EU.3.7.5.,STAMINA(2020)

    المصدر: ISSN: 2165-0497 ; Microbiology Spectrum ; https://riip.hal.science/pasteur-03554629 ; Microbiology Spectrum, 2021, 9 (3), pp.e0063921. ⟨10.1128/Spectrum.00639-21⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34756072; info:eu-repo/grantAgreement//883441/EU/Demonstration of intelligent decision support for pandemic crisis prediction and management within and across European borders/STAMINA; PUBMED: 34756072; PUBMEDCENTRAL: PMC8579926

  16. 16
    Academic Journal

    المساهمون: Virus et Immunité - Virus and immunity (CNRS-UMR3569), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Vaccine Research Institute Créteil, France (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Université Paris Cité (UPCité), Découverte de pathogènes – Pathogen discovery, Institut Pasteur Paris (IP), Immunologie humorale - Humoral Immunology, Institut Pasteur Paris (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Epidémiologie des Maladies Emergentes - Emerging Diseases Epidemiology, Pasteur-Cnam Risques infectieux et émergents (PACRI), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM)-Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), Département de Virologie - Department of Virology, Centre National de Référence des virus des infections respiratoires (dont la grippe) - National Reference Center Virus Influenzae Paris (CNR - laboratoire coordonnateur), Biologie des ARN et virus influenza - RNA Biology of Influenza Virus, Laboratoire commun Pasteur-TheraVectys, Institut Pasteur Paris (IP)-TheraVectys, Virologie Moléculaire et Vaccinologie / Molecular Virology and Vaccinology, Laboratoire d’innovation : vaccins – Innovation lab : vaccines, Plateforme technologique Production et purification de protéines recombinantes – Production and Purification of Recombinant Proteins Technological Platform (PPR), Virologie Structurale - Structural Virology, Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Investigation Clinique et d’Accès aux Ressources Biologiques (Plate-forme) - Clinical Investigation and Access to BioResources (ICAReB), Coordination du Risque Epidémique et Biologique CHU Necker, Hôpital Necker - Enfants Malades AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Etablissement Français du Sang (EFS), EFS, Hôpital de la Cavale Blanche - CHRU Brest (CHU - BREST), CIC Cochin Pasteur (CIC 1417), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Cochin AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôtel-Dieu-Groupe hospitalier Broca-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Santé publique France - French National Public Health Agency Saint-Maurice, France, Centre d'épidémiologie et de santé publique des armées Marseille (CESPA), Service de Santé des Armées, Direction Générale de la Santé (DGS), Ministère de la santé, Conservatoire National des Arts et Métiers CNAM (CNAM), Institut Pasteur Paris (IP)-Conservatoire National des Arts et Métiers CNAM (CNAM), Direction de la recherche médicale de l'Institut Pasteur, École nationale vétérinaire d'Alfort (ENVA), O.S. is funded by Institut Pasteur, ANRS, Sidaction, the Vaccine Research Institute (ANR-10-LABX-77), Labex IBEID (ANR-10-LABX-62-IBEID), “TIMTAMDEN” ANR-14-CE14-0029, “CHIKV-Viro-Immuno” ANR-14-CE14-0015-01, and the Gilead HIV cure program. L.G. is supported by the French Ministry of Higher Education, Research and Innovation. M.E. is funded by Institut Pasteur, Labex IBEID (ANR-10-LABX-62-IBEID), and REACTing, EU RECOVER, and ANR Oh’ticks grants. H.M. is funded by the Institut Pasteur, the Milieu Intérieur Program (ANR-10-LABX-69-01), INSERM, and REACTing and EU RECOVER grants. C.P. is supported by a fellowship from the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (ANRS). S.v.d.W. is funded by Institut Pasteur, CNRS, Université de Paris, Santé publique France, Labex IBEID (ANR-10-LABX-62-IBEID), and REACTing and EU RECOVER grants, ANR-10-LABX-0077,VRI,Initiative for the creation of a Vaccine Research Institute(2010), ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), ANR-14-CE14-0029,TIMTAMDEN,Rôle des récepteurs TIM et TAM dans l'infection des cellules cibles par le virus de la dengue(2014), ANR-14-CE14-0015,CHIKV-Viro-Immuno,Multiplication et Relation avec l'hôte du virus Chikungunya(2014), ANR-16-CE35-0011,OHTicks,Approche One health pour identifier les agents pathogènes transmis par les tiques et responsables de syndromes inexpliqués chez l'Homme et les animaux(2016), European Project: 101003589, H2020-SC1-PHE-CORONAVIRUS-2020,RECOVER(2020)

    المصدر: ISSN: 1946-6234.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/32817357; info:eu-repo/grantAgreement//101003589/EU/Rapid European COVID-19 Emergency Response research/RECOVER; PUBMED: 32817357; PUBMEDCENTRAL: PMC7665313

  17. 17
    Academic Journal

    المساهمون: Quantitative Biosciences Institute UC San Francisco, USA (QBI), University of California San Francisco (UC San Francisco), University of California (UC)-University of California (UC), Gladstone Institutes San Francisco, European Bioinformatics Institute Hinxton (EMBL-EBI), EMBL Heidelberg, Populations virales et Pathogenèse - Viral Populations and Pathogenesis, Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Icahn School of Medicine at Mount Sinai New York (MSSM), Howard Hughes Medical Institute (HHMI), Albert-Ludwigs-Universität Freiburg = University of Freiburg, Virus et Immunité - Virus and immunity (CNRS-UMR3569), Universität Heidelberg Heidelberg = Heidelberg University, Heidelberg University Hospital Heidelberg, Zoic Labs Culver City, CA, Rocky Mountain Laboratories, Vaccine Research Institute Créteil, France (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Centre for Integrative Biological Signalling Studies Freiburg (CIBSS), This research was funded by grants from the National Institutes of Health ( P50AI150476 , U19AI135990 , U19AI135972 , R01AI143292 , R01AI120694 , P01A1063302 , and R01AI122747 to N.J.K., 1R01CA221969 and 1R01CA244550 to K.M.S., R01GM133981 to D.L.S., 1F32CA236347-01 to J.E.M., U19AI118610 to J.R.J., and F32CA239333 to M.B.), Defense Advance Research Projects Agency HR0011-19-2-0020 (to N.J.K., A.G.S., and K.M.S.), by the Laboratory for Genomics Research (LGR) Excellence in Research Award (ERA) from the Innovative Genomics Institute at UC Berkeley (grant number 133122P ), by CRIP (Center for Research for Influenza Pathogenesis), a NIAID-supported Center of Excellence for Influenza Research and Surveillance (CEIRS, contract HHSN272201400008C ) (to A.G.S.), by supplements to NIAID grant U19AI135972 and DoD grant W81XWH-19-PRMRP-FPA (to A.G.S.), and by the generous support of the JPB Foundation , the Open Philanthropy Project (research grant 2020-215611 5384 ), and other philanthropic donations (to A.G.S.), by the Laboratoire d’Excellence “Integrative Biology of Emerging Infectious Diseases” grant ANR-10-LABX-62-IBEID (to M.V.), by the DFG under Germany's Excellence Strategy ( EXC-2189 , project ID 390939984 to R.G.), by a Starting Grant Award from the European Research Council ( ERC-2014-STG 638884 PhosFunc to P.B.), by the Federal Ministry of Education and Research (BMBF, Computational Life Sciences grant 031L0181B to J.S.R.), by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (to E.R.F. and E.D.W.), and by funding from F. Hoffmann-La Roche and Vir Biotechnology and gifts from The Ron Conway Family . K.M.S. is an investigator of the Howard Hughes Medical Institute., ANR-10-LABX-0062,IBEID,Integrative Biology of Emerging Infectious Diseases(2010), European Project: 638884,H2020,ERC-2014-STG,PhosFunc(2015)

    المصدر: ISSN: 0092-8674.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/32645325; info:eu-repo/grantAgreement//638884/EU/Dissecting the functional importance of eukaryotic protein phosphorylation/PhosFunc; PUBMED: 32645325; PUBMEDCENTRAL: PMC7321036

  18. 18
    Academic Journal

    المساهمون: Fred Hutchinson Cancer Research Center Seattle (FHCRC), University of Washington Seattle, Virologie Structurale - Structural Virology, Institut Pasteur Paris (IP)-Centre National de la Recherche Scientifique (CNRS), Massachusetts Institute of Technology (MIT), Harvard University, Howard Hughes Medical Institute Seattle, Howard Hughes Medical Institute (HHMI), This research was supported by the following grants from the NIAID of the NIH: R01AI141707(to J.D.B.), F30AI149928 (to K.H.D.C.) and HHSN272201700059C (to D.V.). This study was also supported bythe National Institute of General Medical Sciences (R01GM120553, D.V.), a Pew Biomedical Scholars Award (D.V.),and Investigators in the Pathogenesis of Infectious Disease Awards from the Burroughs Wellcome Fund (J.D.B.and D.V.). A.B.B. is supported by the National Institutes for Drug Abuse (NIDA) Avenir New Innovator AwardDP2DA040254. J.D.B. is an Investigator of the Howard Hughes Medical Institute.

    المصدر: ISSN: 1999-4915 ; Viruses ; https://pasteur.hal.science/pasteur-02623342 ; Viruses, 2020, 12 (5), pp.513. ⟨10.3390/v12050513⟩.

  19. 19
    Academic Journal

    المساهمون: Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), Institut Laue-Langevin (ILL), Keele Univ, Fac Nat Sci, Keele ST5 5BG, Staffs, England, Graz University of Technology Graz (TU Graz), Australian Nuclear Science and Technology Organisation Australie (ANSTO), Max-Planck-Institut für Festkörperforschung, Max-Planck-Gesellschaft, Christian-Albrechts-Universität zu Kiel = Christian-Albrechts University of Kiel = Université Christian-Albrechts de Kiel (CAU), ANR-10-INBS-0005,FRISBI,Infrastructure Française pour la Biologie Structurale Intégrée(2010)

    المصدر: ISSN: 0021-9797.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/37167912; PUBMED: 37167912; PUBMEDCENTRAL: PMC10147446

  20. 20

    المساهمون: Università degli Studi di Milano = University of Milan (UNIMI), Institut de biologie structurale (IBS - UMR 5075), Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche Interdisciplinaire de Grenoble (IRIG), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), ANR-17-EURE-0003,CBH-EUR-GS,CBH-EUR-GS(2017)

    المصدر: Chemical Communications
    Chemical Communications, 2022, 58 (33), pp.5136-5139. ⟨10.1039/d2cc00121g⟩